These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2282976)

  • 21. Estradiol regulates estrogen receptor mRNA stability.
    Saceda M; Lindsey RK; Solomon H; Angeloni SV; Martin MB
    J Steroid Biochem Mol Biol; 1998 Aug; 66(3):113-20. PubMed ID: 9719445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
    Hall JM; Korach KS
    Mol Endocrinol; 2003 May; 17(5):792-803. PubMed ID: 12586845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
    Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
    Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells.
    Harrington WR; Sengupta S; Katzenellenbogen BS
    Endocrinology; 2006 Aug; 147(8):3843-50. PubMed ID: 16690804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical regulation of estrogen-dependent growth factor gene expression in estrogen receptor (ER)-negative human breast cancer cells stably expressing ER.
    Jeng MH; Jiang SY; Jordan VC
    Cancer Lett; 1994 Jul; 82(2):123-8. PubMed ID: 8050081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site.
    Berthois Y; Pons M; Dussert C; Crastes de Paulet A; Martin PM
    Mol Cell Endocrinol; 1994 Mar; 99(2):259-68. PubMed ID: 8206333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines.
    Saceda M; Grunt TW; Colomer R; Lippman ME; Lupu R; Martin MB
    Endocrinology; 1996 Oct; 137(10):4322-30. PubMed ID: 8828492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol.
    Hung H
    J Cell Physiol; 2004 Feb; 198(2):197-208. PubMed ID: 14603522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells.
    Molis TM; Spriggs LL; Hill SM
    Mol Endocrinol; 1994 Dec; 8(12):1681-90. PubMed ID: 7708056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models.
    Go RE; Hwang KA; Kim CW; Byun YS; Nam KH; Choi KC
    Environ Toxicol; 2017 Oct; 32(10):2225-2233. PubMed ID: 28618207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
    Tian X; Zhang Z
    IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia reduces hormone responsiveness of human breast cancer cells.
    Kurebayashi J; Otsuki T; Moriya T; Sonoo H
    Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of stably transfected fusion protein GFP-estrogen receptor-alpha in MCF-7 human breast cancer cells.
    Zhao H; Hart LL; Keller U; Holth LT; Davie JR
    J Cell Biochem; 2002; 86(2):365-75. PubMed ID: 12112006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the estrogen receptor and its messenger ribonucleic acid in the ovariectomized sheep myometrium and endometrium: the role of estradiol and progesterone.
    Wu WX; Owiny J; Zhang Q; Ma XH; Nathanielsz PW
    Biol Reprod; 1996 Oct; 55(4):762-8. PubMed ID: 8879487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of functional estrogen receptors and galanin messenger ribonucleic acid in immortalized luteinizing hormone-releasing hormone neurons: estrogenic control of galanin gene expression.
    Shen ES; Meade EH; Pérez MC; Deecher DC; Negro-Vilar A; López FJ
    Endocrinology; 1998 Mar; 139(3):939-48. PubMed ID: 9492023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.
    Jeng MH; Shupnik MA; Bender TP; Westin EH; Bandyopadhyay D; Kumar R; Masamura S; Santen RJ
    Endocrinology; 1998 Oct; 139(10):4164-74. PubMed ID: 9751496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.